Search research articles
Contact Us
Filters
Showing results (61-70 of 148) with videos related to
Page
of 15
Sort By:
Epilepsia
|
July 1, 1986
Single dose comparison of the relative bioavailability of phenytoin suspension and extended capsules
W E Fitzsimmons, W R Garnett, T J Comstock, et al.
JAMA
|
January 23, 1987
End-tidal carbon dioxide monitoring during cardiopulmonary resuscitation
A R Garnett, J P Ornato, E R Gonzalez, et al.
Pharmacotherapy
|
February 12, 2002
Pharmacist impact on posttraumatic seizure prophylaxis in patients with head injury
Gretchen M Brophy, Eljim P Tesoro, Gretchen L Schrote, et al.
Journal of Neurological Surgery. Part B, Skull Base
|
March 22, 2017
An Evaluation of Styloidectomy as an Adjunct or Alternative to Jugular Stenting in Idiopathic Intracranial Hypertension and Disturbances of Cranial Venous Outflow
J Nicholas Higgins, Mathew R Garnett, John D Pickard, et al.
American Journal of Hospital Pharmacy
|
May 1, 1981
Effect of telephone follow-up on medication compliance
W R Garnett, L J Davis, J M McKenney, et al.
American Journal of Hospital Pharmacy
|
September 1, 1990
Loss of carbamazepine suspension through nasogastric feeding tubes
A L Clark-Schmidt, W R Garnett, D R Lowe, et al.
Current Medical Research and Opinion
|
November 5, 2003
Simulation of the effect of patient nonadherence on plasma concentrations of carbamazepine from twice-daily extended-release capsules
William R Garnett, Angus M McLean, Yuxin Zhang, et al.
Journal of Clinical Pharmacology
|
December 1, 1989
The effect of everyday exercise on steady state digoxin concentrations
P D Hall, W R Garnett, K W Kolb, et al.
Brain : a Journal of Neurology
|
June 27, 2000
Evidence for cellular damage in normal-appearing white matter correlates with injury severity in patients following traumatic brain injury: A magnetic resonance spectroscopy study
M R Garnett, A M Blamire, B Rajagopalan, et al.
Biopharmaceutics & Drug Disposition
|
November 1, 1992
Comparative bioavailability and steady state fluctuations of Tegretol commercial and carbamazepine OROS tablets in adult and pediatric epileptic patients
K M Thakker, S Mangat, W R Garnett, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 148) with videos related to
Sort By:
Page
of 15
Epilepsia
|
July 1, 1986
Single dose comparison of the relative bioavailability of phenytoin suspension and extended capsules
W E Fitzsimmons, W R Garnett, T J Comstock, et al.
JAMA
|
January 23, 1987
End-tidal carbon dioxide monitoring during cardiopulmonary resuscitation
A R Garnett, J P Ornato, E R Gonzalez, et al.
Pharmacotherapy
|
February 12, 2002
Pharmacist impact on posttraumatic seizure prophylaxis in patients with head injury
Gretchen M Brophy, Eljim P Tesoro, Gretchen L Schrote, et al.
Journal of Neurological Surgery. Part B, Skull Base
|
March 22, 2017
An Evaluation of Styloidectomy as an Adjunct or Alternative to Jugular Stenting in Idiopathic Intracranial Hypertension and Disturbances of Cranial Venous Outflow
J Nicholas Higgins, Mathew R Garnett, John D Pickard, et al.
American Journal of Hospital Pharmacy
|
May 1, 1981
Effect of telephone follow-up on medication compliance
W R Garnett, L J Davis, J M McKenney, et al.
American Journal of Hospital Pharmacy
|
September 1, 1990
Loss of carbamazepine suspension through nasogastric feeding tubes
A L Clark-Schmidt, W R Garnett, D R Lowe, et al.
Current Medical Research and Opinion
|
November 5, 2003
Simulation of the effect of patient nonadherence on plasma concentrations of carbamazepine from twice-daily extended-release capsules
William R Garnett, Angus M McLean, Yuxin Zhang, et al.
Journal of Clinical Pharmacology
|
December 1, 1989
The effect of everyday exercise on steady state digoxin concentrations
P D Hall, W R Garnett, K W Kolb, et al.
Brain : a Journal of Neurology
|
June 27, 2000
Evidence for cellular damage in normal-appearing white matter correlates with injury severity in patients following traumatic brain injury: A magnetic resonance spectroscopy study
M R Garnett, A M Blamire, B Rajagopalan, et al.
Biopharmaceutics & Drug Disposition
|
November 1, 1992
Comparative bioavailability and steady state fluctuations of Tegretol commercial and carbamazepine OROS tablets in adult and pediatric epileptic patients
K M Thakker, S Mangat, W R Garnett, et al.
Page
of 15